Testing novel anti-epileptic compounds in human in vitro seizure model.

Project: Research

Project Details

Project Description

We will test 3 compounds with potential anti-epileptic properties in our human in vitro seizure model derived from stem cells. The contract will be between Monash and Epidarex Exeed Ltd, a Scottish Limited Company with company number SC 39047 and a registered address at 137a George St, Edinburgh, EH2 4JY, United Kingdom
StatusActive
Effective start/end date11/01/2110/04/21

Funding

  • Epidarex Exeed Ltd: AUD22,392.00